Data availability
Anonymized participant-level data cannot be shared due to an increased risk of patient reidentification. Bristol Myers Squibb will consider requests to share anonymized clinical trial data from interventional trials in patients that have completed on or after January 1, 2008. In addition, primary results from these trials must have been published in peer-reviewed journals and the medicines or indications approved in the United States, EU, and other designated markets. Requests to access clinical trial data will be considered case by case and may be submitted to Celgene, a Bristol Myers Squibb Company, using the inquiry form at 